课题基金 / 基金详情

The effects of selective cyclooxygenase-2 inhibitor on fetal ductus arteriosus and kidney

The effects of selective cyclooxygenase-2 inhibitor on fetal ductus arteriosus and kidney
选择性环氧合酶2抑制剂对胎儿动脉导管和肾脏的影响
批准号:
12557086
负责人:
HARADA Kenji
金额:
$7.87万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003

项目摘要

项目成果

HARADA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
背景:最近的研究表明,选择性COX-2抑制剂作为非特异性COX抑制剂,如吲哚美辛(IND),可抑制胎儿动脉导管(DA)的收缩。我们以前曾报道过母体给药引起胎鼠肾组织损伤。目的:评价母体给予选择性环氧合酶-2抑制剂塞来昔布是否会导致胎鼠肾脏的形态损伤,并探讨其与胎儿DA收缩的关系。方法:孕鼠于妊娠第20天经口给予健得丸(10 mg/kg)、塞来昔布(10~60 mg/kg)及赋形剂。24小时后取出胎儿,并分为两个研究组。在DA收缩研究中,采用快速全身冷冻法测定DA与主肺动脉内径的比值(DA/PA)。在形态学研究中,取出肾脏并进行组织病理学检查。数据采用非参数分析进行统计学比较。结果:塞来昔布呈剂量依赖性收缩胎儿DA(10 mg:0.92±0.02、20 mg:0.65±0.12、30 mg:0.35±0.08、40 mg:0.31±0.11、50 mg:0.17±0.10、60 mg:0.11±0.04)。塞来昔布在胎儿肾脏的远端和近端肾小管中引起多种皮质髓坏死和塌陷。IND产生了类似的但更严重的形态损伤。结论:选择性COX-2抑制剂塞来昔布可引起胎鼠形态组织损伤,如吲哚美辛,且这些损伤与胎儿DA收缩无关。
英文摘要
Background : Recent studies demonstrated that selective COX-2 inhibitors constrict the fetal ducus arteriosus (DA) as non-specific COX inhibitors, like indomethacin (IND). We previously reported renal tissue damage in fetal rats induced by maternally administered IND. To evaluate whether a maternally administered selective COX-2 inhibitor, celecoxib, causes morphological renal damages in fetal rats and to evaluate the relation to the fetal DA constriction. Methods : JND (10mg/kg), celecoxibs (10-60mg/kg) and vehicles were administered orally to the pregnant rats on the 20^<th> day of gestation. The fetuses were removed 24 hours after and were divided into two study groups. In the DA constriction study, rapid whole body freezing method was used to obtain the inner diameter ratio of the DA to the main pulmonary artery (DA/PA). In morphological study, the kidneys were removed and examined histopathologically. The data was statistically compared by non-parametric analysis. Result : Celecoxibs constricted the fetal DA dose-dependently (10 mg: 0.92 ± 0.02、20 mg: 0.65 ± 0.12、30 mg: 0.35 ± 0.08、40 mg: 0.31 ± 0.11、50mg: 0.17 ± 0.10、 60 mg: 0.11 ± 0.04). Celecoxibs produced a variety of corticomedullary necrosis and of collapse in distal and proximal tubules in the fetal kidney. IND produced the similar but more severe morphological damages. Conclusion : These data suggested that a selective COX-2 inhibitor, celecoxib, causes morphological tissue damages in fetal rats, like indomethacin, and that these damages are indepen of the fetal DA constriction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of evaluation method for incoming tsunami based on formation process of tsunami deposits
  • 批准号:
    17H02060
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.4万
  • 财政年份:
    2017
  • 负责人:
    HARADA Kenji
  • 依托单位:
Neural substrates and cognition associated with daily physical activity in older persons with cognitive decline
Numerical study of quantum frustrated systems by tensor network methods
  • 批准号:
    23540450
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    HARADA Kenji
  • 依托单位:
Exploring the unconventional continuous phase transition between unrelated symmetry breaking phases
  • 批准号:
    19740237
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.24万
  • 财政年份:
    2007
  • 负责人:
    HARADA Kenji
  • 依托单位:
国内基金
海外基金
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
  • 批准号:
    82372724
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    何竑超
  • 依托单位:
DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
  • 批准号:
    82370719
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹爱丽
  • 依托单位:
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
  • 批准号:
    81101308
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    李海霞
  • 依托单位: